Event Videos
https://pubmed.ncbi.nlm.nih.gov/40019581/ biliary atresia Impact of follow-up liver biopsy on long-term outcomes post-Kasai procedure in patients with biliary atresia Koki Takase 1, Takehisa Ueno 2, Sayaka Matsumoto 1, Naoko Uga 1, Koichi Deguchi 1, Motonari Nomura 1, Miho Watanabe 1, Masafumi Kamiyama 1, Yuko Tazuke 1, Takeshi Kimura 3, Hiroomi Okuyama 1 PMCID: PMC11870969 DOI: 10.1007/s00383-025-05979-y Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39966880/ drug induced Liver function trends in children with suspected drug-induced hepatocellular injury: A survey using an electronic medical records database Masayoshi Nakakuni 1 2, Kosuke Nakano 1, Ayano Inui 3, Shinji Kobayashi 4, Naoko Deguchi 1, Seiji Mitsui 1, Takeshi Kuriyama 1, Seiko Miyazaki 1 2 5 DOI: 10.1111/ped.15847 Published on:
Jan-2025
|
https://pubmed.ncbi.nlm.nih.gov/40019674/ hepatitis c Review Curr Gastroenterol Rep. 2025 Feb 28;27(1):18. Update on Pediatric Hepatitis C Infection Johanna Ferreira 1, Shari Sheflin-Findling 2 PMCID: PMC11870864 DOI: 10.1007/s11894-024-00955-3 Purposeof review: Hepatitis C virus (HCV) infections continue to steadily increase in the United States and remain a major public health challenge. This review aims to provide a comprehensive overview of HCV infection in children, focusing on recent advancements in screening, diagnosis, and treatment. Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39961332/ BILIARY ATRESIA Pediatrics. 2025 Feb 18:e2024070077. Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2-4 Weeks of Life: Clinical Report Sanjiv Harpavat 1, Susan W Aucott 2, Saul J Karpen 3, Benjamin L Shneider 1, Kasper Wang 4; and the SECTION ON GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION; COMMITTEE ON FETUS AND NEWBORN; SECTION ON SURGERY Collaborators, Affiliations expand DOI: 10.1542/peds.2024-070077 Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/40018910/ Hepatic venous wedge pressure gradient measurements in intestinal failure associated liver disease Joseph Valamparampil 1, Rachel M Brown 2, Simon McGuirk 3, Jane Hartley 1, Ye Htun Oo 4, Khalid Sharif 1, Darius Mirza 1 5, Girish L Gupte 1 6 Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39945203/ MASLD Acta Paediatr. 2025 Feb 13. Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity Adi Uretzky 1 2, Eyal Cohen-Sela 1 2, Michal Yackobovitch-Gavan 3, Asaf Ben Simon 1 2, Eyas Midlij 1, Hussein Zaitoon 1 2, Ophir Borger 1 4, Hagar Interator 1 4, Achiya Z Amir 2 5, Hadar Moran-Lev 2 5, Avivit Brener 1 2, Yael Lebenthal 1 2 Affiliations expand DOI: 10.1111/apa.70026 Aim: To explore the relationships between body composition, indices of hepatic fibrosis, and sonographic evidence of hepatic steatosis in children with overweight and obesity. Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39984942/ cholestasis Review Orphanet J Rare Dis. 2025 Feb 21;20(1):80. Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review Giovanni Vitale 1, Marco Sciveres 2, Claudia Mandato 3, Adamo Pio d'Adamo 4 5, Angelo Di Giorgio 6 7 PMCID: PMC11846186 DOI: 10.1186/s13023-025-03599-2 Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39937316/ liver transplant Eur J Pediatr. 2025 Feb 12;184(3):192. Romit Saxena 1, Emma C Alexander 1 2, Sander Bontemps 3, Raman Singla 1, Henkjan J Verkade 4, Vincent E de Meijer 5, Martin C J Kneyber 3 6, Akash Deep 7 8 Affiliations expand PMID: 39937316 PMCID: PMC11821745 DOI: 10.1007/s00431-025-06013-y Abstract Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39967492/ MASLD Pediatr Obes. 2025 Feb 19:e70003. Recent prevalence and trends of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) among US adolescents: 1999 to 2020 Michael Sun 1, Hongbing Sun 2 DOI: 10.1111/ijpo.70003 Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is understudied among US adolescents despite rising obesity rates. Published on:
Feb-2025
|
https://pubmed.ncbi.nlm.nih.gov/39934679/ cholestatic liver disease BMC Gastroenterol. 2025 Feb 11;25(1):75. Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study Yebei Liang # 1 2 3 4, Xiaoqi Ye # 5, Min Pan 1 2 3 4, Yijun Chen 1 2 3 4, Yeqing Yuan 6, Li Luo 7 8 9 10 Abstract Background: Steatotic liver disease (SLD) was a newly proposed disease category derived from metabolic dysfunction-associated fatty liver disease (MAFLD). MAFLD and sarcopenia were independent risk factors for mortality. We aimed to evaluate the impacts of SLD subtypes, MAFLD, and sarcopenia on mortality. Published on:
Feb-2025
|